Effect of Subcision and Suction on Acne Scars
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01696513 |
Recruitment Status :
Active, not recruiting
First Posted : October 1, 2012
Last Update Posted : October 2, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Acne Scars | Procedure: Suction Procedure: Subcision | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Pilot Split Face Randomized, Evaluator Blinded Study on the Effect of Subcision and Suctioning With a Microdermabrasion Device on Rolling Acne Scars |
Study Start Date : | September 2012 |
Estimated Primary Completion Date : | September 2019 |
Estimated Study Completion Date : | September 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Subcision & Suction
Standard treatment for acne scars followed by suction.
|
Procedure: Suction Procedure: Subcision |
Active Comparator: Subcision
Standard treatment for acne scars only
|
Procedure: Subcision |
- Change in acne scarring compared to baseline after treatments [ Time Frame: Baseline and 4 months ]The change in acne scarring is measured using a global scarring grading system to compare baseline scarring to the treatments.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 18 and over
- Have bilateral rolling acne scars
- Are in good health
- Subject has the willingness and ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
Exclusion Criteria:
- Under 18 years of age
- Pregnancy or lactation
- Unable to understand the protocol or give informed consent
- Has mental illness
- Recent Accutane use in the past 6 months
- Prone to hypertrophic and keloidal scarring

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01696513
United States, Illinois | |
Northwestern University Feinberg School of Medicine, Department of Dermatology | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Murad Alam, MD | Northwestern University |
Responsible Party: | Murad Alam, Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation, Northwestern University |
ClinicalTrials.gov Identifier: | NCT01696513 History of Changes |
Other Study ID Numbers: |
STU66710 |
First Posted: | October 1, 2012 Key Record Dates |
Last Update Posted: | October 2, 2018 |
Last Verified: | October 2018 |
Acne Vulgaris Cicatrix Acneiform Eruptions Skin Diseases |
Sebaceous Gland Diseases Fibrosis Pathologic Processes |